Jonathan Hirsch

Jonathan Hirsch serves as the Chief Strategy and Growth Officer at Paradigm, focusing on creating equitable access to clinical trials by alleviating participation burdens on physicians. In addition to this role, Jonathan co-founded Synapticure Inc., where Jonathan also serves as an investor and Chair of the Advisory Board. Jonathan holds investment positions in several healthcare companies, including Arbital Health, Frame, Thyme Care, Forta, and others, while also advising organizations such as Viz.ai and Freenome. Jonathan's academic background includes a Master’s degree in Biological Sciences from Stanford University and a Bachelor’s degree in Biology and Political Science from the University of Chicago.